Azra S Zaidi

Title: Azra S Zaidi: Innovator in Erythrocyte Sedimentation Rate Control

Introduction

Azra S Zaidi is a notable inventor based in Cerritos, California. He has made significant contributions to the field of medical diagnostics, particularly in the development of erythrocyte sedimentation rate (ESR) controls. With a total of three patents to his name, Zaidi's work has enhanced the accuracy and precision of analytical methods used in clinical settings.

Latest Patents

Zaidi's latest patents focus on a three-phase suspension designed for use as an erythrocyte sedimentation rate control. This innovative control comprises three key components: a synthetic plasma base, an aggregating agent such as a high molecular weight polymer or a combination of high molecular weight polymers, and chemically fixed mammalian red blood cells. The design allows users to monitor the accuracy and precision of methods for determining the sedimentation rate of human erythrocytes in whole blood specimens. The chemical fixing of red blood cells enables the ESR control to provide reliable results even in the presence of citrate and/or saline.

Career Highlights

Throughout his career, Azra S Zaidi has worked with various organizations, including Hycor Biomedical, LLC. His expertise in the field has led to advancements in medical diagnostics, particularly in the area of blood analysis.

Collaborations

Zaidi has collaborated with professionals in his field, including Roulhwai Chen, who has contributed to his projects and research endeavors.

Conclusion

Azra S Zaidi's innovative work in the development of erythrocyte sedimentation rate controls has made a significant impact on medical diagnostics. His contributions continue to enhance the accuracy of blood analysis methods, benefiting healthcare professionals and patients alike.